2-((6-(2-carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl)pyridin-2-yl)methyl)butanoic acid

ID: ALA4203027

Chembl Id: CHEMBL4203027

PubChem CID: 145975768

Max Phase: Preclinical

Molecular Formula: C20H18F3N3O4

Molecular Weight: 421.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(Cc1cccc(-n2c(C(N)=O)cc3ccc(OC(F)(F)F)cc32)n1)C(=O)O

Standard InChI:  InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)

Standard InChI Key:  PVKYTTHZBVOPMK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4203027

    ---

Associated Targets(Human)

PLA2G10 Tchem Group X secretory phospholipase A2 (219 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2A Tchem Phospholipase A2 group IIA (1079 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G5 Tchem Phospholipase A2 group V (238 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.38Molecular Weight (Monoisotopic): 421.1249AlogP: 3.68#Rotatable Bonds: 7
Polar Surface Area: 107.44Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.01CX Basic pKa: 2.56CX LogP: 4.28CX LogD: 1.30
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.61Np Likeness Score: -0.91

References

1. Giordanetto F, Knerr L, Nordberg P, Pettersen D, Selmi N, Beisel HG, de la Motte H, Månsson Å, Dahlström M, Broddefalk J, Saarinen G, Klingegård F, Hurt-Camejo E, Rosengren B, Wikström J, Wågberg M, Brengdahl J, Rohman M, Sandmark J, Åkerud T, Roth RG, Jansen F, Ahlqvist M..  (2018)  Design of Selective sPLA2-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl]pyridine-2-yl}propanoic Acid.,  (7): [PMID:30034586] [10.1021/acsmedchemlett.7b00507]
2. Giordanetto F, Knerr L, Nordberg P, Pettersen D, Selmi N, Beisel HG, de la Motte H, Månsson Å, Dahlström M, Broddefalk J, Saarinen G, Klingegård F, Hurt-Camejo E, Rosengren B, Wikström J, Wågberg M, Brengdahl J, Rohman M, Sandmark J, Åkerud T, Roth RG, Jansen F, Ahlqvist M..  (2018)  Design of Selective sPLA2-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl]pyridine-2-yl}propanoic Acid.,  (7): [PMID:30034586] [10.1021/acsmedchemlett.7b00507]

Source